vs

Side-by-side financial comparison of MEDIFAST INC (MED) and SANDRIDGE ENERGY INC (SD). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $39.4M, roughly 1.9× SANDRIDGE ENERGY INC). On growth, SANDRIDGE ENERGY INC posted the faster year-over-year revenue change (1.1% vs -36.9%). SANDRIDGE ENERGY INC produced more free cash flow last quarter ($14.4M vs $-6.6M). Over the past eight quarters, SANDRIDGE ENERGY INC's revenue compounded faster (14.1% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

SandRidge Energy, Inc. is a company engaged in hydrocarbon exploration in the Mid-Continent region of the United States. It is organized in Delaware and headquartered in Oklahoma City, Oklahoma.

MED vs SD — Head-to-Head

Bigger by revenue
MED
MED
1.9× larger
MED
$75.1M
$39.4M
SD
Growing faster (revenue YoY)
SD
SD
+38.0% gap
SD
1.1%
-36.9%
MED
More free cash flow
SD
SD
$21.1M more FCF
SD
$14.4M
$-6.6M
MED
Faster 2-yr revenue CAGR
SD
SD
Annualised
SD
14.1%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MED
MED
SD
SD
Revenue
$75.1M
$39.4M
Net Profit
$21.6M
Gross Margin
69.4%
Operating Margin
-10.4%
38.5%
Net Margin
54.9%
Revenue YoY
-36.9%
1.1%
Net Profit YoY
23.1%
EPS (diluted)
$-1.64
$0.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
SD
SD
Q4 25
$75.1M
$39.4M
Q3 25
$89.4M
$39.8M
Q2 25
$105.6M
$34.5M
Q1 25
$115.7M
$42.6M
Q4 24
$119.0M
$39.0M
Q3 24
$140.2M
$30.1M
Q2 24
$168.6M
$26.0M
Q1 24
$174.7M
$30.3M
Net Profit
MED
MED
SD
SD
Q4 25
$21.6M
Q3 25
$-2.3M
$16.0M
Q2 25
$2.5M
$19.6M
Q1 25
$-772.0K
$13.0M
Q4 24
$17.6M
Q3 24
$1.1M
$25.5M
Q2 24
$-8.2M
$8.8M
Q1 24
$8.3M
$11.1M
Gross Margin
MED
MED
SD
SD
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
MED
MED
SD
SD
Q4 25
-10.4%
38.5%
Q3 25
-4.6%
37.8%
Q2 25
-1.0%
53.7%
Q1 25
-1.1%
28.6%
Q4 24
0.6%
25.9%
Q3 24
1.5%
28.3%
Q2 24
-4.7%
23.9%
Q1 24
4.5%
27.8%
Net Margin
MED
MED
SD
SD
Q4 25
54.9%
Q3 25
-2.5%
40.1%
Q2 25
2.3%
56.6%
Q1 25
-0.7%
30.6%
Q4 24
45.1%
Q3 24
0.8%
84.8%
Q2 24
-4.8%
33.9%
Q1 24
4.8%
36.7%
EPS (diluted)
MED
MED
SD
SD
Q4 25
$-1.64
$0.59
Q3 25
$-0.21
$0.43
Q2 25
$0.22
$0.53
Q1 25
$-0.07
$0.35
Q4 24
$0.08
$0.46
Q3 24
$0.10
$0.69
Q2 24
$-0.75
$0.24
Q1 24
$0.76
$0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
SD
SD
Cash + ST InvestmentsLiquidity on hand
$167.3M
$111.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$198.9M
$510.9M
Total Assets
$248.0M
$644.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
SD
SD
Q4 25
$167.3M
$111.0M
Q3 25
$173.5M
$101.2M
Q2 25
$162.7M
$102.8M
Q1 25
$164.6M
$99.7M
Q4 24
$162.3M
$98.1M
Q3 24
$170.0M
$92.7M
Q2 24
$163.5M
$209.9M
Q1 24
$156.4M
$207.0M
Stockholders' Equity
MED
MED
SD
SD
Q4 25
$198.9M
$510.9M
Q3 25
$214.7M
$492.4M
Q2 25
$216.0M
$480.2M
Q1 25
$211.0M
$464.9M
Q4 24
$210.1M
$460.5M
Q3 24
$207.3M
$446.8M
Q2 24
$205.3M
$424.8M
Q1 24
$211.0M
$419.7M
Total Assets
MED
MED
SD
SD
Q4 25
$248.0M
$644.0M
Q3 25
$268.2M
$619.0M
Q2 25
$269.3M
$602.3M
Q1 25
$280.0M
$588.3M
Q4 24
$284.2M
$581.5M
Q3 24
$291.2M
$565.2M
Q2 24
$293.5M
$529.6M
Q1 24
$302.8M
$527.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
SD
SD
Operating Cash FlowLast quarter
$-5.3M
$31.7M
Free Cash FlowOCF − Capex
$-6.6M
$14.4M
FCF MarginFCF / Revenue
-8.8%
36.6%
Capex IntensityCapex / Revenue
1.8%
43.8%
Cash ConversionOCF / Net Profit
1.46×
TTM Free Cash FlowTrailing 4 quarters
$1.2M
$41.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
SD
SD
Q4 25
$-5.3M
$31.7M
Q3 25
$12.1M
$25.3M
Q2 25
$-3.4M
$22.9M
Q1 25
$3.4M
$20.3M
Q4 24
$-4.9M
$26.0M
Q3 24
$9.1M
$20.8M
Q2 24
$13.1M
$11.4M
Q1 24
$7.3M
$15.7M
Free Cash Flow
MED
MED
SD
SD
Q4 25
$-6.6M
$14.4M
Q3 25
$10.8M
$5.9M
Q2 25
$-4.8M
$7.3M
Q1 25
$1.9M
$13.9M
Q4 24
$-7.2M
$13.2M
Q3 24
$7.7M
$10.8M
Q2 24
$11.1M
$9.0M
Q1 24
$5.4M
$14.6M
FCF Margin
MED
MED
SD
SD
Q4 25
-8.8%
36.6%
Q3 25
12.0%
14.9%
Q2 25
-4.5%
21.0%
Q1 25
1.6%
32.7%
Q4 24
-6.1%
33.8%
Q3 24
5.5%
36.1%
Q2 24
6.6%
34.5%
Q1 24
3.1%
48.1%
Capex Intensity
MED
MED
SD
SD
Q4 25
1.8%
43.8%
Q3 25
1.5%
48.6%
Q2 25
1.3%
45.2%
Q1 25
1.3%
15.0%
Q4 24
1.9%
32.9%
Q3 24
1.0%
33.3%
Q2 24
1.1%
9.4%
Q1 24
1.1%
3.7%
Cash Conversion
MED
MED
SD
SD
Q4 25
1.46×
Q3 25
1.58×
Q2 25
-1.36×
1.17×
Q1 25
1.56×
Q4 24
1.48×
Q3 24
8.04×
0.82×
Q2 24
1.30×
Q1 24
0.88×
1.41×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MED
MED

Segment breakdown not available.

SD
SD

Oil Reserves$19.0M48%
Natural Gas Reserves$11.6M30%
Natural Gas Liquids Reserves$8.7M22%

Related Comparisons